

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | defense response to fungus (GO:0050832) | 8.08267284 |
| 2 | leukocyte aggregation (GO:0070486) | 7.82061808 |
| 3 | detection of bacterium (GO:0016045) | 7.72137020 |
| 4 | desmosome organization (GO:0002934) | 7.29039409 |
| 5 | leukocyte migration involved in inflammatory response (GO:0002523) | 7.25317090 |
| 6 | detection of other organism (GO:0098543) | 6.85330307 |
| 7 | establishment of skin barrier (GO:0061436) | 6.73623647 |
| 8 | regulation of water loss via skin (GO:0033561) | 6.28392737 |
| 9 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 6.08546510 |
| 10 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 6.08546510 |
| 11 | response to peptidoglycan (GO:0032494) | 5.56500732 |
| 12 | response to fungus (GO:0009620) | 5.33535047 |
| 13 | positive regulation of type 2 immune response (GO:0002830) | 5.24412792 |
| 14 | keratinization (GO:0031424) | 5.22417187 |
| 15 | antibacterial humoral response (GO:0019731) | 5.18523823 |
| 16 | production of molecular mediator involved in inflammatory response (GO:0002532) | 5.16784526 |
| 17 | mucosal immune response (GO:0002385) | 5.03547106 |
| 18 | hydrogen peroxide biosynthetic process (GO:0050665) | 5.03344328 |
| 19 | antimicrobial humoral response (GO:0019730) | 4.97052381 |
| 20 | negative regulation of interleukin-12 production (GO:0032695) | 4.92978794 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 4.86924250 |
| 22 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.83836211 |
| 23 | sequestering of metal ion (GO:0051238) | 4.83685484 |
| 24 | organ or tissue specific immune response (GO:0002251) | 4.78788576 |
| 25 | regulation of T cell tolerance induction (GO:0002664) | 4.75331279 |
| 26 | cellular response to type I interferon (GO:0071357) | 4.68972116 |
| 27 | type I interferon signaling pathway (GO:0060337) | 4.68972116 |
| 28 | innate immune response in mucosa (GO:0002227) | 4.67877999 |
| 29 | superoxide anion generation (GO:0042554) | 4.67805417 |
| 30 | response to type I interferon (GO:0034340) | 4.64768964 |
| 31 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.61560100 |
| 32 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.55130780 |
| 33 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.54050929 |
| 34 | keratinocyte differentiation (GO:0030216) | 4.53535877 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 4.53283607 |
| 36 | disruption of cells of other organism (GO:0044364) | 4.50500862 |
| 37 | killing of cells of other organism (GO:0031640) | 4.50500862 |
| 38 | lipoxygenase pathway (GO:0019372) | 4.50198987 |
| 39 | positive regulation by symbiont of host defense response (GO:0052509) | 4.43746700 |
| 40 | modulation by symbiont of host defense response (GO:0052031) | 4.43746700 |
| 41 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.43746700 |
| 42 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.43746700 |
| 43 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.43746700 |
| 44 | modulation by symbiont of host immune response (GO:0052553) | 4.43746700 |
| 45 | positive regulation of cAMP-mediated signaling (GO:0043950) | 4.43219432 |
| 46 | reactive oxygen species biosynthetic process (GO:1903409) | 4.42368297 |
| 47 | neutrophil mediated immunity (GO:0002446) | 4.40224076 |
| 48 | interferon-gamma secretion (GO:0072643) | 4.36837690 |
| 49 | neutrophil activation (GO:0042119) | 4.36478481 |
| 50 | T-helper 1 type immune response (GO:0042088) | 4.30162393 |
| 51 | respiratory burst (GO:0045730) | 4.28243113 |
| 52 | regulation of tolerance induction (GO:0002643) | 4.23910115 |
| 53 | multicellular organismal water homeostasis (GO:0050891) | 4.18603959 |
| 54 | cellular extravasation (GO:0045123) | 4.16596222 |
| 55 | macrophage activation involved in immune response (GO:0002281) | 4.14388212 |
| 56 | primary alcohol catabolic process (GO:0034310) | 4.13416004 |
| 57 | granulocyte activation (GO:0036230) | 4.10680066 |
| 58 | chronic inflammatory response (GO:0002544) | 4.01258545 |
| 59 | myeloid leukocyte mediated immunity (GO:0002444) | 4.01256974 |
| 60 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.00423197 |
| 61 | positive regulation of antigen processing and presentation (GO:0002579) | 3.98856735 |
| 62 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.94307459 |
| 63 | hemidesmosome assembly (GO:0031581) | 3.91488587 |
| 64 | sphingoid metabolic process (GO:0046519) | 3.90531575 |
| 65 | positive regulation of vesicle fusion (GO:0031340) | 3.89162275 |
| 66 | detection of molecule of bacterial origin (GO:0032490) | 3.87217330 |
| 67 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.87025223 |
| 68 | regulation of antigen processing and presentation (GO:0002577) | 3.82029224 |
| 69 | kynurenine metabolic process (GO:0070189) | 3.80572374 |
| 70 | positive regulation of tolerance induction (GO:0002645) | 3.79505582 |
| 71 | leukotriene metabolic process (GO:0006691) | 3.74851271 |
| 72 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.74528550 |
| 73 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.74512728 |
| 74 | positive regulation of mast cell activation (GO:0033005) | 3.74173444 |
| 75 | phagosome maturation (GO:0090382) | 3.73004074 |
| 76 | regulation of interferon-alpha production (GO:0032647) | 3.71845852 |
| 77 | regulation of chronic inflammatory response (GO:0002676) | 3.70576090 |
| 78 | defense response to Gram-positive bacterium (GO:0050830) | 3.69755901 |
| 79 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.68878787 |
| 80 | water homeostasis (GO:0030104) | 3.67361630 |
| 81 | lymphocyte chemotaxis (GO:0048247) | 3.66816994 |
| 82 | indole-containing compound catabolic process (GO:0042436) | 3.65953088 |
| 83 | indolalkylamine catabolic process (GO:0046218) | 3.65953088 |
| 84 | tryptophan catabolic process (GO:0006569) | 3.65953088 |
| 85 | neutrophil chemotaxis (GO:0030593) | 3.65468101 |
| 86 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.65239337 |
| 87 | protein localization to kinetochore (GO:0034501) | 3.63510185 |
| 88 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.61757120 |
| 89 | cellular response to interferon-gamma (GO:0071346) | 3.61028253 |
| 90 | T cell migration (GO:0072678) | 3.60519974 |
| 91 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.59308726 |
| 92 | response to interferon-gamma (GO:0034341) | 3.58663231 |
| 93 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.58508665 |
| 94 | negative regulation of cell killing (GO:0031342) | 3.57989101 |
| 95 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.57989101 |
| 96 | regulation of interleukin-12 production (GO:0032655) | 3.57874533 |
| 97 | positive regulation of interferon-alpha production (GO:0032727) | 3.57321549 |
| 98 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.57276786 |
| 99 | regulation of type 2 immune response (GO:0002828) | 3.56691234 |
| 100 | B cell mediated immunity (GO:0019724) | 3.56355128 |
| 101 | regulation of natural killer cell differentiation (GO:0032823) | 3.56230887 |
| 102 | molting cycle (GO:0042303) | 3.55543007 |
| 103 | hair cycle (GO:0042633) | 3.55543007 |
| 104 | neutrophil migration (GO:1990266) | 3.54679814 |
| 105 | detection of external biotic stimulus (GO:0098581) | 3.52974279 |
| 106 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.52044108 |
| 107 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.51821657 |
| 108 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.50069950 |
| 109 | eosinophil chemotaxis (GO:0048245) | 3.49531587 |
| 110 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.49320028 |
| 111 | defense response to protozoan (GO:0042832) | 3.49299664 |
| 112 | positive regulation of interleukin-12 production (GO:0032735) | 3.48054994 |
| 113 | leukotriene biosynthetic process (GO:0019370) | 3.46120757 |
| 114 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.45872966 |
| 115 | epidermal cell differentiation (GO:0009913) | 3.45686489 |
| 116 | regulation of mast cell activation (GO:0033003) | 3.45495771 |
| 117 | regulation of mononuclear cell migration (GO:0071675) | 3.42128148 |
| 118 | response to interferon-beta (GO:0035456) | 3.40660726 |
| 119 | ethanol metabolic process (GO:0006067) | 3.37729563 |
| 120 | sphingosine metabolic process (GO:0006670) | 3.37230820 |
| 121 | regulation of T-helper cell differentiation (GO:0045622) | 3.35890417 |
| 122 | microglial cell activation (GO:0001774) | 3.33609076 |
| 123 | regulation of hypersensitivity (GO:0002883) | 3.32033496 |
| 124 | protein localization to chromosome, centromeric region (GO:0071459) | 3.29555250 |
| 125 | regulation of interleukin-8 secretion (GO:2000482) | 3.28818496 |
| 126 | regulation of chemokine secretion (GO:0090196) | 3.28339753 |
| 127 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.27641034 |
| 128 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.27557937 |
| 129 | keratinocyte proliferation (GO:0043616) | 3.25522216 |
| 130 | NADPH regeneration (GO:0006740) | 3.24730190 |
| 131 | pentose-phosphate shunt (GO:0006098) | 3.24680288 |
| 132 | regulation of ruffle assembly (GO:1900027) | 3.24613610 |
| 133 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.23213426 |
| 134 | negative regulation of stress fiber assembly (GO:0051497) | 3.21684482 |
| 135 | prostanoid biosynthetic process (GO:0046457) | 3.20880936 |
| 136 | prostaglandin biosynthetic process (GO:0001516) | 3.20880936 |
| 137 | detection of biotic stimulus (GO:0009595) | 3.19976456 |
| 138 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.18958409 |
| 139 | negative regulation of interleukin-10 production (GO:0032693) | 3.18702299 |
| 140 | negative regulation of viral genome replication (GO:0045071) | 3.17562704 |
| 141 | regulation of interleukin-10 production (GO:0032653) | 3.17405377 |
| 142 | regulation of interleukin-1 secretion (GO:0050704) | 3.17371064 |
| 143 | response to protozoan (GO:0001562) | 3.16568367 |
| 144 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.16216446 |
| 145 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.14587693 |
| 146 | positive regulation of interleukin-1 beta production (GO:0032731) | 3.13848336 |
| 147 | positive regulation of osteoblast proliferation (GO:0033690) | 3.13320860 |
| 148 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.13097558 |
| 149 | icosanoid secretion (GO:0032309) | 3.12902940 |
| 150 | arachidonic acid secretion (GO:0050482) | 3.12902940 |
| 151 | eosinophil migration (GO:0072677) | 3.12757177 |
| 152 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.10567599 |
| 153 | positive regulation of mast cell degranulation (GO:0043306) | 3.09681016 |
| 154 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.09681016 |
| 155 | positive regulation of interleukin-10 production (GO:0032733) | 3.08809457 |
| 156 | positive regulation of interferon-beta production (GO:0032728) | 3.07701435 |
| 157 | keratinocyte development (GO:0003334) | 3.07519751 |
| 158 | peptide cross-linking (GO:0018149) | 3.05718987 |
| 159 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.05332491 |
| 160 | fatty acid derivative biosynthetic process (GO:1901570) | 3.05136235 |
| 161 | icosanoid biosynthetic process (GO:0046456) | 3.05136235 |
| 162 | regulation of mast cell degranulation (GO:0043304) | 3.04419284 |
| 163 | positive regulation of interleukin-1 production (GO:0032732) | 3.03405709 |
| 164 | ectoderm development (GO:0007398) | 3.02960006 |
| 165 | tryptophan metabolic process (GO:0006568) | 3.00954346 |
| 166 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.00928067 |
| 167 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.00225173 |
| 168 | pentose metabolic process (GO:0019321) | 2.99914839 |
| 169 | regulation of T-helper 1 type immune response (GO:0002825) | 2.99787973 |
| 170 | diol metabolic process (GO:0034311) | 2.98748629 |
| 171 | granulocyte chemotaxis (GO:0071621) | 2.98147457 |
| 172 | myeloid dendritic cell differentiation (GO:0043011) | 2.97962491 |
| 173 | dendritic cell chemotaxis (GO:0002407) | 2.97954400 |
| 174 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.97745818 |
| 175 | regulation of leukocyte degranulation (GO:0043300) | 2.97535807 |
| 176 | defense response to virus (GO:0051607) | 2.96945396 |
| 177 | positive regulation of defense response to virus by host (GO:0002230) | 2.96891606 |
| 178 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.95582156 |
| 179 | granulocyte migration (GO:0097530) | 2.95167991 |
| 180 | cellular response to interferon-beta (GO:0035458) | 2.93063359 |
| 181 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.92406127 |
| 182 | regulation of regulatory T cell differentiation (GO:0045589) | 2.92095646 |
| 183 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.90712913 |
| 184 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.90524247 |
| 185 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.90251578 |
| 186 | response to host immune response (GO:0052572) | 2.90251578 |
| 187 | negative regulation of interferon-gamma production (GO:0032689) | 2.88118748 |
| 188 | defense response to bacterium (GO:0042742) | 2.86335519 |
| 189 | regulation of regulated secretory pathway (GO:1903305) | 2.85924407 |
| 190 | positive regulation of regulated secretory pathway (GO:1903307) | 2.85876283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.83064220 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.97979750 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.91027249 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.15974451 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.00740939 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.93468852 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.12573698 |
| 8 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.74637999 |
| 9 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 2.64845879 |
| 10 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.51472218 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.21575406 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.14763805 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.12485397 |
| 14 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.07614872 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.07406039 |
| 16 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.06085690 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.02355016 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 11.2549370 |
| 19 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.98777251 |
| 20 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.98777251 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.98041179 |
| 22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.97243711 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.96579081 |
| 24 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.96164889 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.86848717 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.85655730 |
| 27 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.84333575 |
| 28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.83070738 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.78798814 |
| 30 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.71701353 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.69429878 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.67750615 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.65208647 |
| 34 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.63778929 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.61198916 |
| 36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.60722908 |
| 37 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.54883738 |
| 38 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.54729435 |
| 39 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.54525073 |
| 40 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.54314735 |
| 41 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.48624227 |
| 42 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46929811 |
| 43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46769291 |
| 44 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.46386854 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.44386109 |
| 46 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.43760537 |
| 47 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.41554369 |
| 48 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.38056018 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36959116 |
| 50 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.36123445 |
| 51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.35950552 |
| 52 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.34855578 |
| 53 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.33524010 |
| 54 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.33419662 |
| 55 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32963209 |
| 56 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31982710 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30611009 |
| 58 | ATF3_27146783_Chip-Seq_COLON_Human | 1.30607688 |
| 59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.29845975 |
| 60 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.29507557 |
| 61 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29060305 |
| 62 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.26150282 |
| 63 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.26093220 |
| 64 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24406673 |
| 65 | MYB_26560356_Chip-Seq_TH1_Human | 1.23231928 |
| 66 | RXR_22108803_ChIP-Seq_LS180_Human | 1.22274193 |
| 67 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.22087710 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21357205 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20046056 |
| 70 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.19631030 |
| 71 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.19601826 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.19576183 |
| 73 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17673999 |
| 74 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14080901 |
| 75 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.12870378 |
| 76 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12525639 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11938630 |
| 78 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.11432203 |
| 79 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.09843291 |
| 80 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.09735508 |
| 81 | MYB_26560356_Chip-Seq_TH2_Human | 1.09519952 |
| 82 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05206179 |
| 83 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04897940 |
| 84 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03549805 |
| 85 | CJUN_26792858_Chip-Seq_BT549_Human | 1.03237111 |
| 86 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.02872534 |
| 87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02088619 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01833179 |
| 89 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01662079 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01563398 |
| 91 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00184398 |
| 92 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99659181 |
| 93 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.99175721 |
| 94 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.95012871 |
| 95 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.94199596 |
| 96 | MAF_26560356_Chip-Seq_TH1_Human | 0.91906867 |
| 97 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.91461856 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90978796 |
| 99 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90432698 |
| 100 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.90203916 |
| 101 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.89713692 |
| 102 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.89568342 |
| 103 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.89259624 |
| 104 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.87802231 |
| 105 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.87469020 |
| 106 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86213750 |
| 107 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.85899411 |
| 108 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84241521 |
| 109 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.81581880 |
| 110 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.80988164 |
| 111 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.80983746 |
| 112 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.80786142 |
| 113 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80632959 |
| 114 | UTX_26944678_Chip-Seq_JUKART_Human | 0.80475028 |
| 115 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.80460544 |
| 116 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79029431 |
| 117 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79024358 |
| 118 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79011048 |
| 119 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78819779 |
| 120 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78723795 |
| 121 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.77573471 |
| 122 | GATA3_26560356_Chip-Seq_TH2_Human | 0.77072772 |
| 123 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.76657530 |
| 124 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.76011821 |
| 125 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.75848441 |
| 126 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.75069645 |
| 127 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74733241 |
| 128 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73818389 |
| 129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72514939 |
| 130 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.72409787 |
| 131 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.71979051 |
| 132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71697616 |
| 133 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71697616 |
| 134 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.70559479 |
| 135 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69473585 |
| 136 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69128078 |
| 137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.68614021 |
| 138 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.68604342 |
| 139 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.68436820 |
| 140 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.68065581 |
| 141 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.67811086 |
| 142 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.67594130 |
| 143 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.66828064 |
| 144 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.64058488 |
| 145 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.64052374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002796_impaired_skin_barrier | 5.20585490 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 4.21791194 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.17596244 |
| 4 | MP0006082_CNS_inflammation | 3.57265444 |
| 5 | MP0003436_decreased_susceptibility_to | 3.37750563 |
| 6 | MP0003941_abnormal_skin_development | 3.18303058 |
| 7 | MP0005451_abnormal_body_composition | 3.09770964 |
| 8 | MP0003453_abnormal_keratinocyte_physiol | 3.06902833 |
| 9 | MP0005671_abnormal_response_to | 3.04493913 |
| 10 | MP0005501_abnormal_skin_physiology | 3.02084557 |
| 11 | MP0004381_abnormal_hair_follicle | 2.95972776 |
| 12 | MP0002060_abnormal_skin_morphology | 2.92631927 |
| 13 | MP0001216_abnormal_epidermal_layer | 2.85526791 |
| 14 | MP0000579_abnormal_nail_morphology | 2.66257065 |
| 15 | MP0002277_abnormal_respiratory_mucosa | 2.62151500 |
| 16 | MP0001851_eye_inflammation | 2.59549601 |
| 17 | MP0009278_abnormal_bone_marrow | 2.50853889 |
| 18 | MP0003303_peritoneal_inflammation | 2.39698173 |
| 19 | MP0004947_skin_inflammation | 2.24328577 |
| 20 | MP0002254_reproductive_system_inflammat | 2.22330267 |
| 21 | MP0005275_abnormal_skin_tensile | 2.20521134 |
| 22 | MP0002098_abnormal_vibrissa_morphology | 2.14375431 |
| 23 | MP0010678_abnormal_skin_adnexa | 2.13074139 |
| 24 | MP0009785_altered_susceptibility_to | 2.12856860 |
| 25 | MP0003566_abnormal_cell_adhesion | 2.12004159 |
| 26 | MP0010771_integument_phenotype | 2.10925802 |
| 27 | MP0008789_abnormal_olfactory_epithelium | 2.08064109 |
| 28 | MP0000383_abnormal_hair_follicle | 2.04665883 |
| 29 | MP0005499_abnormal_olfactory_system | 2.01447187 |
| 30 | MP0005394_taste/olfaction_phenotype | 2.01447187 |
| 31 | MP0002009_preneoplasia | 1.98977163 |
| 32 | MP0000647_abnormal_sebaceous_gland | 1.92423623 |
| 33 | MP0004510_myositis | 1.89564307 |
| 34 | MP0005310_abnormal_salivary_gland | 1.80822982 |
| 35 | MP0003693_abnormal_embryo_hatching | 1.74393633 |
| 36 | MP0000377_abnormal_hair_follicle | 1.69061366 |
| 37 | MP0008469_abnormal_protein_level | 1.68762810 |
| 38 | MP0005023_abnormal_wound_healing | 1.65646031 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.63475194 |
| 40 | MP0002419_abnormal_innate_immunity | 1.61724078 |
| 41 | MP0000467_abnormal_esophagus_morphology | 1.60706750 |
| 42 | MP0003183_abnormal_peptide_metabolism | 1.60382902 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.57699584 |
| 44 | MP0001984_abnormal_olfaction | 1.56646317 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.54672415 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.54672415 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.54220046 |
| 48 | MP0002877_abnormal_melanocyte_morpholog | 1.53696766 |
| 49 | MP0003646_muscle_fatigue | 1.51300895 |
| 50 | MP0002132_abnormal_respiratory_system | 1.49586337 |
| 51 | MP0000716_abnormal_immune_system | 1.48316208 |
| 52 | MP0003724_increased_susceptibility_to | 1.48043411 |
| 53 | MP0009840_abnormal_foam_cell | 1.44389576 |
| 54 | MP0009931_abnormal_skin_appearance | 1.42931013 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.39821147 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.39624204 |
| 57 | MP0001849_ear_inflammation | 1.37379331 |
| 58 | MP0001191_abnormal_skin_condition | 1.37063704 |
| 59 | MP0000427_abnormal_hair_cycle | 1.36402428 |
| 60 | MP0001346_abnormal_lacrimal_gland | 1.35740678 |
| 61 | MP0003195_calcinosis | 1.28109450 |
| 62 | MP0005076_abnormal_cell_differentiation | 1.26223993 |
| 63 | MP0000604_amyloidosis | 1.25811257 |
| 64 | MP0000858_altered_metastatic_potential | 1.25071862 |
| 65 | MP0009053_abnormal_anal_canal | 1.23381205 |
| 66 | MP0002139_abnormal_hepatobiliary_system | 1.22310801 |
| 67 | MP0005025_abnormal_response_to | 1.20701770 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 1.19734763 |
| 69 | MP0000566_synostosis | 1.19733350 |
| 70 | MP0002398_abnormal_bone_marrow | 1.18190268 |
| 71 | MP0002405_respiratory_system_inflammati | 1.17508413 |
| 72 | MP0003075_altered_response_to | 1.16841864 |
| 73 | MP0003191_abnormal_cellular_cholesterol | 1.15084783 |
| 74 | MP0005164_abnormal_response_to | 1.12692033 |
| 75 | MP0005166_decreased_susceptibility_to | 1.09886012 |
| 76 | MP0002429_abnormal_blood_cell | 1.09082015 |
| 77 | MP0000569_abnormal_digit_pigmentation | 1.09016472 |
| 78 | MP0001881_abnormal_mammary_gland | 1.08879607 |
| 79 | MP0004264_abnormal_extraembryonic_tissu | 1.06967019 |
| 80 | MP0002148_abnormal_hypersensitivity_rea | 1.06493209 |
| 81 | MP0004782_abnormal_surfactant_physiolog | 1.05014197 |
| 82 | MP0003806_abnormal_nucleotide_metabolis | 1.02761293 |
| 83 | MP0000762_abnormal_tongue_morphology | 1.02630306 |
| 84 | MP0005000_abnormal_immune_tolerance | 1.02174422 |
| 85 | MP0010352_gastrointestinal_tract_polyps | 1.02033497 |
| 86 | MP0003763_abnormal_thymus_physiology | 1.01863560 |
| 87 | MP0000343_altered_response_to | 1.01316203 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.99956119 |
| 89 | MP0001873_stomach_inflammation | 0.98492565 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.98340104 |
| 91 | MP0009763_increased_sensitivity_to | 0.97953582 |
| 92 | MP0002998_abnormal_bone_remodeling | 0.96339152 |
| 93 | MP0003136_yellow_coat_color | 0.95239102 |
| 94 | MP0000689_abnormal_spleen_morphology | 0.94310159 |
| 95 | MP0001663_abnormal_digestive_system | 0.94209903 |
| 96 | MP0002332_abnormal_exercise_endurance | 0.93978920 |
| 97 | MP0005390_skeleton_phenotype | 0.93172467 |
| 98 | MP0008260_abnormal_autophagy | 0.92603110 |
| 99 | MP0003828_pulmonary_edema | 0.92037284 |
| 100 | MP0009764_decreased_sensitivity_to | 0.90636656 |
| 101 | MP0002837_dystrophic_cardiac_calcinosis | 0.90533274 |
| 102 | MP0002722_abnormal_immune_system | 0.88937315 |
| 103 | MP0003448_altered_tumor_morphology | 0.87127041 |
| 104 | MP0004185_abnormal_adipocyte_glucose | 0.85130091 |
| 105 | MP0003866_abnormal_defecation | 0.85014777 |
| 106 | MP0000367_abnormal_coat/_hair | 0.84929589 |
| 107 | MP0001845_abnormal_inflammatory_respons | 0.84274743 |
| 108 | MP0000627_abnormal_mammary_gland | 0.84227548 |
| 109 | MP0002420_abnormal_adaptive_immunity | 0.83257945 |
| 110 | MP0001819_abnormal_immune_cell | 0.82556159 |
| 111 | MP0003300_gastrointestinal_ulcer | 0.81932112 |
| 112 | MP0003878_abnormal_ear_physiology | 0.81629735 |
| 113 | MP0005377_hearing/vestibular/ear_phenot | 0.81629735 |
| 114 | MP0004883_abnormal_blood_vessel | 0.80122628 |
| 115 | MP0002006_tumorigenesis | 0.79951772 |
| 116 | MP0010155_abnormal_intestine_physiology | 0.79614907 |
| 117 | MP0003690_abnormal_glial_cell | 0.78442015 |
| 118 | MP0003656_abnormal_erythrocyte_physiolo | 0.77848340 |
| 119 | MP0001243_abnormal_dermal_layer | 0.77583459 |
| 120 | MP0002452_abnormal_antigen_presenting | 0.76910026 |
| 121 | MP0006054_spinal_hemorrhage | 0.76749397 |
| 122 | MP0002693_abnormal_pancreas_physiology | 0.74784624 |
| 123 | MP0001800_abnormal_humoral_immune | 0.73525816 |
| 124 | MP0001853_heart_inflammation | 0.72597644 |
| 125 | MP0000015_abnormal_ear_pigmentation | 0.71310687 |
| 126 | MP0000685_abnormal_immune_system | 0.70506881 |
| 127 | MP0008874_decreased_physiological_sensi | 0.67434373 |
| 128 | MP0005408_hypopigmentation | 0.66878104 |
| 129 | MP0004043_abnormal_pH_regulation | 0.64727913 |
| 130 | MP0005464_abnormal_platelet_physiology | 0.64271343 |
| 131 | MP0002166_altered_tumor_susceptibility | 0.64129319 |
| 132 | MP0000371_diluted_coat_color | 0.63292511 |
| 133 | MP0000920_abnormal_myelination | 0.63149643 |
| 134 | MP0005319_abnormal_enzyme/_coenzyme | 0.62911234 |
| 135 | MP0008004_abnormal_stomach_pH | 0.60921759 |
| 136 | MP0002653_abnormal_ependyma_morphology | 0.59548490 |
| 137 | MP0002723_abnormal_immune_serum | 0.59128488 |
| 138 | MP0002136_abnormal_kidney_physiology | 0.58463532 |
| 139 | MP0002133_abnormal_respiratory_system | 0.57915148 |
| 140 | MP0005388_respiratory_system_phenotype | 0.57915148 |
| 141 | MP0002233_abnormal_nose_morphology | 0.56719572 |
| 142 | MP0005387_immune_system_phenotype | 0.56540172 |
| 143 | MP0001790_abnormal_immune_system | 0.56540172 |
| 144 | MP0005381_digestive/alimentary_phenotyp | 0.53992412 |
| 145 | MP0005174_abnormal_tail_pigmentation | 0.53887385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.73091411 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.24073682 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.82619393 |
| 4 | Congenital ichthyosiform erythroderma (HP:0007431) | 5.64692234 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.53811895 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 5.38412729 |
| 7 | Optic neuritis (HP:0100653) | 5.38412729 |
| 8 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 5.27968396 |
| 9 | Lip pit (HP:0100267) | 4.99457408 |
| 10 | Hypotrichosis (HP:0001006) | 4.86895472 |
| 11 | Obstructive lung disease (HP:0006536) | 4.41262133 |
| 12 | Chronic obstructive pulmonary disease (HP:0006510) | 4.41262133 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 4.39909252 |
| 14 | Increased IgE level (HP:0003212) | 4.35120782 |
| 15 | Right ventricular cardiomyopathy (HP:0011663) | 4.13018391 |
| 16 | Onycholysis (HP:0001806) | 4.06485447 |
| 17 | Ectropion (HP:0000656) | 4.03284971 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 3.99554691 |
| 19 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.92625212 |
| 20 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.92625212 |
| 21 | Abnormality of glycolipid metabolism (HP:0010969) | 3.92625212 |
| 22 | Urticaria (HP:0001025) | 3.84474095 |
| 23 | Gingivitis (HP:0000230) | 3.79352348 |
| 24 | Plantar hyperkeratosis (HP:0007556) | 3.69488932 |
| 25 | Keratoconjunctivitis (HP:0001096) | 3.67940113 |
| 26 | Parakeratosis (HP:0001036) | 3.67652904 |
| 27 | Hemoptysis (HP:0002105) | 3.67245301 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.66978588 |
| 29 | Stomatitis (HP:0010280) | 3.58095793 |
| 30 | Mediastinal lymphadenopathy (HP:0100721) | 3.55596728 |
| 31 | Pulmonary infiltrates (HP:0002113) | 3.51410313 |
| 32 | Woolly hair (HP:0002224) | 3.49268288 |
| 33 | Abnormality of macrophages (HP:0004311) | 3.49052600 |
| 34 | Abnormality of nail color (HP:0100643) | 3.45146370 |
| 35 | Vasculitis (HP:0002633) | 3.44959327 |
| 36 | Increased IgM level (HP:0003496) | 3.25650262 |
| 37 | Chronic otitis media (HP:0000389) | 3.25287444 |
| 38 | Palmoplantar hyperkeratosis (HP:0000972) | 3.23600862 |
| 39 | Alopecia of scalp (HP:0002293) | 3.22251125 |
| 40 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.16581150 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 3.16581150 |
| 42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.13687544 |
| 43 | Curly hair (HP:0002212) | 3.08718215 |
| 44 | Papilledema (HP:0001085) | 3.08407701 |
| 45 | Autoimmune hemolytic anemia (HP:0001890) | 3.04110665 |
| 46 | Fragile nails (HP:0001808) | 3.04024592 |
| 47 | Sparse eyelashes (HP:0000653) | 3.03429550 |
| 48 | Palmar hyperkeratosis (HP:0010765) | 3.00263783 |
| 49 | Pili torti (HP:0003777) | 2.99926124 |
| 50 | Milia (HP:0001056) | 2.99055299 |
| 51 | Popliteal pterygium (HP:0009756) | 2.98061930 |
| 52 | Erythema (HP:0010783) | 2.93125420 |
| 53 | Premature loss of primary teeth (HP:0006323) | 2.90042068 |
| 54 | Corneal erosion (HP:0200020) | 2.89790518 |
| 55 | Erythroderma (HP:0001019) | 2.85839982 |
| 56 | Hypergammaglobulinemia (HP:0010702) | 2.84592388 |
| 57 | Cellulitis (HP:0100658) | 2.84057434 |
| 58 | Encephalitis (HP:0002383) | 2.83105249 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.82302455 |
| 60 | Hypohidrosis (HP:0000966) | 2.80546464 |
| 61 | Pustule (HP:0200039) | 2.80283176 |
| 62 | Stenosis of the external auditory canal (HP:0000402) | 2.80166217 |
| 63 | Malnutrition (HP:0004395) | 2.79855952 |
| 64 | Arterial thrombosis (HP:0004420) | 2.79230500 |
| 65 | Nail dystrophy (HP:0008404) | 2.79119869 |
| 66 | Thick nail (HP:0001805) | 2.77941966 |
| 67 | Ventricular tachycardia (HP:0004756) | 2.76031515 |
| 68 | Gangrene (HP:0100758) | 2.72681515 |
| 69 | Hypoplastic labia majora (HP:0000059) | 2.69469358 |
| 70 | Recurrent viral infections (HP:0004429) | 2.67933668 |
| 71 | Anorexia (HP:0002039) | 2.62319280 |
| 72 | Increased cerebral lipofuscin (HP:0011813) | 2.61997403 |
| 73 | Abnormal hemoglobin (HP:0011902) | 2.61299259 |
| 74 | Loss of speech (HP:0002371) | 2.61168694 |
| 75 | Sepsis (HP:0100806) | 2.58747657 |
| 76 | Chest pain (HP:0100749) | 2.54562887 |
| 77 | Abnormality of T cell number (HP:0011839) | 2.54061484 |
| 78 | Recurrent skin infections (HP:0001581) | 2.53452947 |
| 79 | Myositis (HP:0100614) | 2.53319361 |
| 80 | Oligodontia (HP:0000677) | 2.51681604 |
| 81 | Stomach cancer (HP:0012126) | 2.51249559 |
| 82 | Spontaneous hematomas (HP:0007420) | 2.48158616 |
| 83 | Abnormality of the labia majora (HP:0012881) | 2.47879893 |
| 84 | Skin ulcer (HP:0200042) | 2.46249498 |
| 85 | Glomerulonephritis (HP:0000099) | 2.45925298 |
| 86 | Blepharitis (HP:0000498) | 2.44874622 |
| 87 | Abnormal blistering of the skin (HP:0008066) | 2.42468823 |
| 88 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.42172500 |
| 89 | Dysostosis multiplex (HP:0000943) | 2.42073546 |
| 90 | Leukocytosis (HP:0001974) | 2.41748294 |
| 91 | Amyloidosis (HP:0011034) | 2.38682882 |
| 92 | Peritonitis (HP:0002586) | 2.36829159 |
| 93 | Congenital, generalized hypertrichosis (HP:0004540) | 2.36703642 |
| 94 | Vacuolated lymphocytes (HP:0001922) | 2.34839658 |
| 95 | Prostate neoplasm (HP:0100787) | 2.34790197 |
| 96 | Pruritus (HP:0000989) | 2.33775795 |
| 97 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.32486850 |
| 98 | Disinhibition (HP:0000734) | 2.31539435 |
| 99 | Abnormality of the pleura (HP:0002103) | 2.31089180 |
| 100 | Recurrent bronchitis (HP:0002837) | 2.30863136 |
| 101 | Pulmonary embolism (HP:0002204) | 2.29535360 |
| 102 | Absent eyebrow (HP:0002223) | 2.26510479 |
| 103 | T lymphocytopenia (HP:0005403) | 2.26449352 |
| 104 | Abnormality of the prostate (HP:0008775) | 2.25288079 |
| 105 | Cheilitis (HP:0100825) | 2.24465571 |
| 106 | Recurrent fungal infections (HP:0002841) | 2.16355032 |
| 107 | Abnormality of the endocardium (HP:0004306) | 2.15350344 |
| 108 | Abnormality of the axillary hair (HP:0100134) | 2.13728315 |
| 109 | Abnormality of secondary sexual hair (HP:0009888) | 2.13728315 |
| 110 | Vertigo (HP:0002321) | 2.10717837 |
| 111 | Keratitis (HP:0000491) | 2.07621026 |
| 112 | Acanthosis nigricans (HP:0000956) | 2.07543407 |
| 113 | Polyneuropathy (HP:0001271) | 2.06210317 |
| 114 | Joint swelling (HP:0001386) | 2.04971286 |
| 115 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.04706405 |
| 116 | Nasal polyposis (HP:0100582) | 2.02955308 |
| 117 | Asymmetry of the thorax (HP:0001555) | 2.02431875 |
| 118 | Male infertility (HP:0003251) | 2.02120978 |
| 119 | Episodic fever (HP:0001954) | 2.02013129 |
| 120 | Abnormality of B cell number (HP:0010975) | 2.01960282 |
| 121 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.01075757 |
| 122 | Abnormality of the pericardium (HP:0001697) | 2.00585429 |
| 123 | Increased serum ferritin (HP:0003281) | 1.99473494 |
| 124 | Orchitis (HP:0100796) | 1.98982730 |
| 125 | Abnormality of the nasal mucosa (HP:0000433) | 1.98526675 |
| 126 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.95699395 |
| 127 | Alveolar cell carcinoma (HP:0006519) | 1.95577822 |
| 128 | Eosinophilia (HP:0001880) | 1.94436651 |
| 129 | Meningitis (HP:0001287) | 1.93619629 |
| 130 | Skin rash (HP:0000988) | 1.93597633 |
| 131 | Albinism (HP:0001022) | 1.93202383 |
| 132 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.92894089 |
| 133 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.92894089 |
| 134 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.92894089 |
| 135 | Gingival bleeding (HP:0000225) | 1.92596875 |
| 136 | Skin pits (HP:0100276) | 1.89894064 |
| 137 | Areflexia of lower limbs (HP:0002522) | 1.83757348 |
| 138 | Labial hypoplasia (HP:0000066) | 1.83610123 |
| 139 | Palmoplantar keratoderma (HP:0000982) | 1.82625592 |
| 140 | Sparse scalp hair (HP:0002209) | 1.79590902 |
| 141 | Type I diabetes mellitus (HP:0100651) | 1.77871821 |
| 142 | Ridged nail (HP:0001807) | 1.77854565 |
| 143 | Periodontitis (HP:0000704) | 1.77630365 |
| 144 | Dry skin (HP:0000958) | 1.74739937 |
| 145 | Anhidrosis (HP:0000970) | 1.74333502 |
| 146 | Hypoplastic female external genitalia (HP:0012815) | 1.74199498 |
| 147 | Reticulocytopenia (HP:0001896) | 1.71504119 |
| 148 | Pyloric stenosis (HP:0002021) | 1.71164139 |
| 149 | Hematochezia (HP:0002573) | 1.70565894 |
| 150 | Preauricular pit (HP:0004467) | 1.69222702 |
| 151 | Periauricular skin pits (HP:0100277) | 1.69222702 |
| 152 | Recurrent pneumonia (HP:0006532) | 1.64904319 |
| 153 | Abnormality of the labia (HP:0000058) | 1.64292146 |
| 154 | Dehydration (HP:0001944) | 1.63387540 |
| 155 | Natal tooth (HP:0000695) | 1.62146502 |
| 156 | Hypoparathyroidism (HP:0000829) | 1.61013744 |
| 157 | Concave nail (HP:0001598) | 1.59411198 |
| 158 | Abnormal foot bone ossification (HP:0010675) | 1.58400695 |
| 159 | Hypermelanotic macule (HP:0001034) | 1.56750094 |
| 160 | Distal lower limb muscle weakness (HP:0009053) | 1.53291073 |
| 161 | Keratoconjunctivitis sicca (HP:0001097) | 1.51730849 |
| 162 | Abnormality of the gastric mucosa (HP:0004295) | 1.51530984 |
| 163 | Metaphyseal irregularity (HP:0003025) | 1.51138134 |
| 164 | Abnormal hair laboratory examination (HP:0003328) | 1.50812964 |
| 165 | Xerostomia (HP:0000217) | 1.48198248 |
| 166 | Follicular hyperkeratosis (HP:0007502) | 1.47738479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K3 | 4.55109674 |
| 2 | RIPK4 | 3.81293956 |
| 3 | TRPM7 | 3.76340359 |
| 4 | IRAK4 | 3.37313933 |
| 5 | ERBB3 | 3.28826666 |
| 6 | JAK3 | 3.09187851 |
| 7 | STK10 | 3.03270343 |
| 8 | GRK7 | 2.88791964 |
| 9 | IRAK3 | 2.80718340 |
| 10 | MATK | 2.65559332 |
| 11 | BLK | 2.61087595 |
| 12 | JAK1 | 2.52549776 |
| 13 | MST4 | 2.52419514 |
| 14 | MAP4K1 | 2.42593906 |
| 15 | ERN1 | 2.41358408 |
| 16 | MAPKAPK3 | 2.28878978 |
| 17 | TBK1 | 2.16358029 |
| 18 | IKBKB | 2.03780974 |
| 19 | ADRBK2 | 2.02582036 |
| 20 | RIPK1 | 1.99444325 |
| 21 | MAP3K2 | 1.99124539 |
| 22 | TAOK1 | 1.98461430 |
| 23 | MAP3K12 | 1.98380040 |
| 24 | KIT | 1.98036675 |
| 25 | FGR | 1.96681595 |
| 26 | CSK | 1.93034371 |
| 27 | MAP3K9 | 1.93027856 |
| 28 | RPS6KB2 | 1.87586587 |
| 29 | FGFR4 | 1.84341720 |
| 30 | EPHB1 | 1.81291102 |
| 31 | MAP2K3 | 1.78338519 |
| 32 | CLK1 | 1.73933424 |
| 33 | TEC | 1.71930170 |
| 34 | MST1R | 1.69817690 |
| 35 | TAOK3 | 1.66409101 |
| 36 | IRAK1 | 1.62352087 |
| 37 | TESK1 | 1.61476273 |
| 38 | LRRK2 | 1.57672221 |
| 39 | FRK | 1.51304982 |
| 40 | STK4 | 1.48884147 |
| 41 | LYN | 1.45665025 |
| 42 | LATS1 | 1.40481894 |
| 43 | BTK | 1.39063872 |
| 44 | RPS6KA4 | 1.37643083 |
| 45 | FER | 1.36115277 |
| 46 | NEK1 | 1.35405673 |
| 47 | ACVR1B | 1.32245198 |
| 48 | PTK2 | 1.31692402 |
| 49 | EPHA2 | 1.31169209 |
| 50 | NEK2 | 1.27493094 |
| 51 | LATS2 | 1.22731402 |
| 52 | CDC42BPA | 1.22070330 |
| 53 | MAP3K13 | 1.21353128 |
| 54 | CHUK | 1.10312427 |
| 55 | DDR2 | 1.05750445 |
| 56 | MAP2K6 | 1.04474034 |
| 57 | MAP3K11 | 0.99441326 |
| 58 | HCK | 0.98593107 |
| 59 | LCK | 0.98581726 |
| 60 | STK24 | 0.98002513 |
| 61 | ZAP70 | 0.94766313 |
| 62 | PBK | 0.88721526 |
| 63 | MAPKAPK2 | 0.88187541 |
| 64 | ITK | 0.86534000 |
| 65 | BRSK2 | 0.86157031 |
| 66 | TTN | 0.86156073 |
| 67 | CSF1R | 0.83915965 |
| 68 | PRPF4B | 0.81735499 |
| 69 | EPHA3 | 0.81614875 |
| 70 | AURKB | 0.80070750 |
| 71 | NLK | 0.78708940 |
| 72 | MAP3K14 | 0.75592773 |
| 73 | DYRK3 | 0.74586869 |
| 74 | IRAK2 | 0.74050813 |
| 75 | CDK9 | 0.72718620 |
| 76 | NME2 | 0.63867648 |
| 77 | PIM2 | 0.63033176 |
| 78 | STK38L | 0.61801987 |
| 79 | TGFBR2 | 0.61352981 |
| 80 | ABL1 | 0.60948563 |
| 81 | MAP3K6 | 0.60435776 |
| 82 | STK3 | 0.60055345 |
| 83 | MAP3K1 | 0.58190485 |
| 84 | MAP3K8 | 0.57906905 |
| 85 | AURKA | 0.57226193 |
| 86 | CDK6 | 0.57039973 |
| 87 | TYK2 | 0.56863083 |
| 88 | SIK3 | 0.56683440 |
| 89 | MARK3 | 0.56501106 |
| 90 | LIMK1 | 0.55330215 |
| 91 | CDK4 | 0.53621358 |
| 92 | PTK6 | 0.52849881 |
| 93 | TNK2 | 0.52258446 |
| 94 | HIPK2 | 0.52007013 |
| 95 | TESK2 | 0.51384890 |
| 96 | CDK3 | 0.50927573 |
| 97 | MAPK4 | 0.50377481 |
| 98 | EIF2AK2 | 0.50367152 |
| 99 | STK38 | 0.50277330 |
| 100 | PIM1 | 0.49908248 |
| 101 | IKBKE | 0.47341480 |
| 102 | STK11 | 0.45666932 |
| 103 | PRKCQ | 0.43595473 |
| 104 | SGK3 | 0.42645904 |
| 105 | ABL2 | 0.42548049 |
| 106 | DAPK2 | 0.42142523 |
| 107 | FES | 0.41687051 |
| 108 | OXSR1 | 0.41603275 |
| 109 | BUB1 | 0.40333699 |
| 110 | GRK1 | 0.40208523 |
| 111 | PDK1 | 0.38455562 |
| 112 | TAOK2 | 0.38428361 |
| 113 | MELK | 0.37854132 |
| 114 | PIK3CG | 0.35800969 |
| 115 | MAPK11 | 0.34349775 |
| 116 | PDPK1 | 0.34180202 |
| 117 | EGFR | 0.32576436 |
| 118 | MAP3K5 | 0.31258626 |
| 119 | IGF1R | 0.29407035 |
| 120 | TTK | 0.28930835 |
| 121 | DYRK2 | 0.28341409 |
| 122 | GRK6 | 0.28222275 |
| 123 | YES1 | 0.28213120 |
| 124 | BMPR2 | 0.27444112 |
| 125 | PIK3CA | 0.27182232 |
| 126 | CDK7 | 0.26832073 |
| 127 | TXK | 0.25440974 |
| 128 | SYK | 0.25410146 |
| 129 | MET | 0.24967151 |
| 130 | MOS | 0.23040531 |
| 131 | PRKCI | 0.22761497 |
| 132 | FGFR1 | 0.22658329 |
| 133 | PRKAA2 | 0.22434478 |
| 134 | PRKCD | 0.22398922 |
| 135 | KDR | 0.22246331 |
| 136 | PDGFRB | 0.22244271 |
| 137 | KSR2 | 0.21684020 |
| 138 | FGFR3 | 0.21210791 |
| 139 | FYN | 0.21201616 |
| 140 | JAK2 | 0.20703009 |
| 141 | MAPK7 | 0.20200196 |
| 142 | RPS6KA5 | 0.19761478 |
| 143 | ERBB2 | 0.18875944 |
| 144 | INSR | 0.18423698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.62056326 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.15767697 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.10936758 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.07092209 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.85889652 |
| 6 | Histidine metabolism_Homo sapiens_hsa00340 | 2.70732862 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.66397108 |
| 8 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.65932559 |
| 9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.65892851 |
| 10 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.59298847 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.59122476 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.48453989 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.46300284 |
| 14 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.40426701 |
| 15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.19800770 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.17049951 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.14586268 |
| 18 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.13750280 |
| 19 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.03281067 |
| 20 | Retinol metabolism_Homo sapiens_hsa00830 | 1.88424638 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.88250919 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.85526411 |
| 23 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.79805055 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.78736165 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.70303115 |
| 26 | Adherens junction_Homo sapiens_hsa04520 | 1.67386474 |
| 27 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.67017558 |
| 28 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.66186748 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.64029161 |
| 30 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.62122921 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.61295307 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.60609088 |
| 33 | Bladder cancer_Homo sapiens_hsa05219 | 1.57549578 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.49618997 |
| 35 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.48135142 |
| 36 | Sulfur relay system_Homo sapiens_hsa04122 | 1.47086054 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.38623737 |
| 38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.32116291 |
| 39 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.26500883 |
| 40 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.25668105 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.21673737 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.21439403 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09677184 |
| 44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.08910177 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.07889005 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.07606603 |
| 47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.07545250 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04746093 |
| 49 | Tuberculosis_Homo sapiens_hsa05152 | 1.04425865 |
| 50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.04071485 |
| 51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.02865845 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 1.00540516 |
| 53 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.00376685 |
| 54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.98699891 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.98650233 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.97724430 |
| 57 | Tight junction_Homo sapiens_hsa04530 | 0.97370954 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96828572 |
| 59 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.95722421 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94775543 |
| 61 | Amoebiasis_Homo sapiens_hsa05146 | 0.94096888 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.93197035 |
| 63 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.92405178 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.90348069 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.90297717 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.89775455 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 0.89507259 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.85361473 |
| 69 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.85020340 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.83604890 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.82758858 |
| 72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.82083983 |
| 73 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.80421498 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.79644946 |
| 75 | Cell cycle_Homo sapiens_hsa04110 | 0.77789174 |
| 76 | Salmonella infection_Homo sapiens_hsa05132 | 0.77482425 |
| 77 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.76140052 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75758140 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73506578 |
| 80 | ABC transporters_Homo sapiens_hsa02010 | 0.73392614 |
| 81 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71416742 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70878553 |
| 83 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.70461221 |
| 84 | Mineral absorption_Homo sapiens_hsa04978 | 0.68983653 |
| 85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68836410 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68229318 |
| 87 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67276087 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66501287 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63653076 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63579093 |
| 91 | Hepatitis B_Homo sapiens_hsa05161 | 0.62776705 |
| 92 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.59189215 |
| 93 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59114436 |
| 94 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58892911 |
| 95 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.57152770 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57012009 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55845247 |
| 98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54984930 |
| 99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54686244 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53489983 |
| 101 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53257853 |
| 102 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.53238090 |
| 103 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52546177 |
| 104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52076108 |
| 105 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50837846 |
| 106 | Ribosome_Homo sapiens_hsa03010 | 0.50121524 |
| 107 | Legionellosis_Homo sapiens_hsa05134 | 0.49686555 |
| 108 | Prostate cancer_Homo sapiens_hsa05215 | 0.48240359 |
| 109 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48032688 |
| 110 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.47486169 |
| 111 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.47209801 |
| 112 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46796847 |
| 113 | Influenza A_Homo sapiens_hsa05164 | 0.46636709 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44788025 |
| 115 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.44354799 |
| 116 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43782960 |
| 117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43766370 |
| 118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43739458 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42549383 |
| 120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42125398 |
| 121 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.41569678 |
| 122 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41028100 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40985747 |
| 124 | Malaria_Homo sapiens_hsa05144 | 0.40634235 |
| 125 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39839923 |
| 126 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39039012 |
| 127 | Apoptosis_Homo sapiens_hsa04210 | 0.38279270 |
| 128 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38118005 |
| 129 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.37717736 |
| 130 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33188647 |
| 131 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32253534 |
| 132 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29212312 |
| 133 | HTLV-I infection_Homo sapiens_hsa05166 | 0.20744573 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.18446074 |
| 135 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.17952889 |
| 136 | Prion diseases_Homo sapiens_hsa05020 | 0.15826112 |
| 137 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.14741409 |
| 138 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.13500474 |
| 139 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.12192005 |
| 140 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.12018089 |
| 141 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.09767205 |
| 142 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.07751681 |

